Risk of Reactivation of Occult Hepatitis B in Cancer Patients During Immunotherapy.

NCT06347588 · clinicaltrials.gov ↗

ACTIVE_NOT_RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Occult Hepatitis B Infection in Cancer Patients

Interventions

OTHER: Observational: Blood sample of HVB-specific Elispot assay, HBSAg, HBV-DNA

Sponsor

Fondazione IRCCS Policlinico San Matteo di Pavia